Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | DPP4 | P27487 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6041181 | 1.00 | THRB (0.61) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL5966402 | 0.92 | KMT2A (0.55) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL5966403 | 0.92 | KMT2A (0.55) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL15649102 | 0.85 | CISD1 (0.65) | CA12CA1CA2CA3CA4 | |
| SCHEMBL4076403 | 0.84 | THRB (0.64) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL4076401 | 0.84 | THRB (0.64) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL28349619 | 0.83 | MAPT (0.55) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL5216755 | 0.83 | THRB (0.57) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL5216742 | 0.83 | THRB (0.57) | THRBATMHCAR2CA12AKR1B10 | |
| SCHEMBL28520144 | 0.81 | CISD1 (0.57) | CISD1STSLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172102-A1 | USE OF OLIGOAPIOGALACTURONANS AND THEIR DERIVATIVES TO SIMULATE DEFENCE AND RESISTANCE REACTIONS IN PLANTS AGAINST BIOTIC AND ABIOTIC STRESS SOURCES | ALGIE PLUS (FR) | 2011-07-14 | — | — | US | claimed |
| US-20110172102-A1 | USE OF OLIGOAPIOGALACTURONANS AND THEIR DERIVATIVES TO SIMULATE DEFENCE AND RESISTANCE REACTIONS IN PLANTS AGAINST BIOTIC AND ABIOTIC STRESS SOURCES | ALGIE PLUS (FR) | 2011-07-14 | — | — | US | disclosed |
| US-20110100371-A1 | ANTI-VIRAL PROPERTIES OF ZOSTERIC ACID AND RELATED MOLECULES | FLORIDA GULF COAST UNIVERSITY (US) | 2011-05-05 | — | — | US | disclosed |
| US-7618697-B2 | Coatings, films; environmentally friendly | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-11-17 | — | — | US | disclosed |
| WO-2009012157-A2 | ANTI-VIRAL PROPERTIES OF ZOSTERIC ACID AND RELATED MOLECULES | FLORIDA GULF COAST UNIVERSITY (US) | 2009-01-22 | — | — | WO | disclosed |
| US-20070128151-A1 | Coatings, films; environmentally friendly | CIBA SPECIALTY CHEMICALS CORP. | 2007-06-07 | — | — | US | disclosed |
| US-20060053510-A1 | Transgenic plants incorporating traits of Zostera marina | CUTLER, ELIOT | 2006-03-09 | — | — | US | disclosed |
| US-6841718-B2 | Transgenic plants incorporating traits of Zostera marina | CERNO BIOSCIENCES LLC (US) | 2005-01-11 | — | — | US | disclosed |
| US-20020016980-A1 | Transgenic plants incorporating traits of zostera marina | CERNOFINA, LLC | 2002-02-07 | — | — | US | disclosed |
| WO-2001085971-A2 | TRANSGENIC PLANTS INCORPORATING_GENES OF ZOSTERA MARINA | PHYCOGEN, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| US-5990336-A | Synthesis and purification of zosteric acid | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 1999-11-23 | — | — | US | disclosed |
| US-4410626-A | Process for the production of 7α-methoxycephalosporin derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4259326-A | ANTIBIOTICS, BACTERICIDES | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070128151-A1 | Coatings, films; environmentally friendly | CUTA, GAP43, NAPA | THRB 3546/4885ATM 4869/4885HCAR2 279/4885 |
| US-20110100371-A1 | ANTI-VIRAL PROPERTIES OF ZOSTERIC ACID AND RELATED MOLECULES | HAVCR2, ZC3HAV1, ZC3HAV1L | THRB 4840/4885ATM 4883/4885HCAR2 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.